Last reviewed · How we verify

NCT06092528

Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency

Recruiting now NA Last updated 5 December 2023
What this trial tests

NA trial testing Inspiratory muscle training in Primary Immunodeficiency in 40 participants. Currently enrolling.

Timeline
1 November 2023
Primary endpoint
20 September 2025
20 September 2026

Quick facts

Lead sponsorGazi University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment40
Start date1 November 2023
Primary completion20 September 2025
Estimated completion20 September 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

Adults 6 to 18, any sex, with Primary Immunodeficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary immunodeficiencies (PID) are a heterogeneous group of diseases that occur as a result of disorders that affect the development, differentiation and/or function of various cells and building blocks in the immune system. Among the symptoms and complications of PID, pulmonary complications are very common and significantly increase the morbidity and mortality of the disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method).
    Dominguez-Pinilla N, González-Granado LI, Gonzaga A, López Diaz M, et al · · 2025 · cited 3× · PMID 40188166 · DOI 10.1186/s13287-025-04289-3

Verify or expand the search:

Other trials of Inspiratory muscle training

Trials testing the same drug.

Other recruiting trials for Primary Immunodeficiency

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06092528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing